Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation (PERISCOPE) - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00225277

Locations


United States, Alabama

	Birmingham, Alabama, United States

United States, Arizona

	Phoenix, Arizona, United States

United States, California

	Huntington Beach, California, United States

	Los Angeles, California, United States

	Sacramento, California, United States

	San Diego, California, United States

	Torrance, California, United States

United States, Connecticut

	Bridgeport, Connecticut, United States

	Farmington, Connecticut, United States

United States, District of Columbia

	Washington, District of Columbia, United States

United States, Florida

	Bay Pines, Florida, United States

	Jacksonville, Florida, United States

United States, Georgia

	Decatur, Georgia, United States

United States, Idaho

	Boise, Idaho, United States

United States, Illinois

	Chicago, Illinois, United States

United States, Kentucky

	Edgewood, Kentucky, United States

	Lexington, Kentucky, United States

	Louisville, Kentucky, United States

United States, Louisiana

	New Orleans, Louisiana, United States

United States, Maine

	Bangor, Maine, United States

United States, Maryland

	Baltimore, Maryland, United States

United States, Michigan

	Detroit, Michigan, United States

	Flint, Michigan, United States

	Kalamazoo, Michigan, United States

	Petoskey, Michigan, United States

	Pontiac, Michigan, United States

	Royal Oak, Michigan, United States

	Ypsilanti, Michigan, United States

United States, Minnesota

	Duluth, Minnesota, United States

	Minneapolis, Minnesota, United States

	St. Cloud, Minnesota, United States

United States, Missouri

	Columbia, Missouri, United States

United States, New Jersey

	Camden, New Jersey, United States

United States, New York

	Albany, New York, United States

	Rochester, New York, United States

	Mineola, New York, United States

	New York, New York, United States

	Bronx, New York, United States

	Troy, New York, United States

	West Islip, New York, United States

	Williamsville, New York, United States

United States, North Carolina

	Winston-Salem, North Carolina, United States

United States, Ohio

	Cincinnati, Ohio, United States

	Cleveland, Ohio, United States

	Columbus, Ohio, United States

	Westlake, Ohio, United States

United States, Oklahoma

	Oklahoma City, Oklahoma, United States

	Tulsa, Oklahoma, United States

United States, Pennsylvania

	Abington, Pennsylvania, United States

	Bryn Mawr, Pennsylvania, United States

	Hershey, Pennsylvania, United States

	Pittsburgh, Pennsylvania, United States

United States, Rhode Island

	Providence, Rhode Island, United States

United States, South Carolina

	Greenville, South Carolina, United States

United States, Tennessee

	Memphis, Tennessee, United States

	Oak Ridge, Tennessee, United States

United States, Texas

	Amarillo, Texas, United States

	Houston, Texas, United States

	Lubbock, Texas, United States

	San Antonio, Texas, United States

United States, Virginia

	Charlottesville, Virginia, United States

	Norfolk, Virginia, United States

	Richmond, Virginia, United States

United States, Washington

	Everett, Washington, United States

United States, Wisconsin

	Green Bay, Wisconsin, United States

Argentina

	Multiple Cities, Argentina

Canada, Alberta

	Edmonton, Alberta, Canada

Canada, British Columbia

	Victoria, British Columbia, Canada

	Vancouver, British Columbia, Canada

Canada, Manitoba

	Winnepeg, Manitoba, Canada

Canada, New Brunswick

	Saint John, New Brunswick, Canada

Canada, Ontario

	London, Ontario, Canada

	Ottawa, Ontario, Canada

Canada, Quebec

	Montreal, Quebec, Canada

	Sainte Foy, Quebec, Canada

Canada, Saskatchewan

	Saskatoon, Saskatchewan, Canada

Chile

	Multiple Cities, Chile

Sponsors and Collaborators

Takeda Global Research & Development Center, Inc.

The Cleveland Clinic

Investigators


Study Director:	Alfonso Perez, MD	Takeda Global Research & Development Center, Inc.